RINUAGENE
Dead / Abandoned — Abandoned — no statement of use filed (as of 14 Oct 2025)
What this means for you
This application is over — abandoned 14 Oct 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90898397
- Mark type
- Stylized text
- Filed
- 24 Aug 2021
- Published for opposition
- 23 Aug 2022
- Abandoned
- 14 Oct 2025
- Attorney of record
- Eric Lamb
Goods and services
- Class 001 — Chemicals: Biochemicals, namely, proteins, protein-encoding nucleic acids, polypeptide-encoding nucleic acids and polypeptides for use in vivo, ex vivo, on vivo or in vitro scientific research and medical research, and for use in the manufacture of food or nutritional supplements; biochemicals, namely, proteins, protein-encoding nucleic acids, polypeptide-encoding nucleic acids and polypeptides for use in the manufacture of pharmaceuticals for treating rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders and reproductive disorders; active chemical ingredients for use in manufacture of biotherapeutics, biosimilars and therapeutics products for treating infectious diseases and cancer; chemicals for use in biotherapeutics, biosimilars and therapeutics product development and manufacturing processes; adjuvants for use in manufacture of vaccines; reagents for testing sterility of pharmaceuticals; protein arrays and nucleotide arrays for scientific and medical laboratory use for scientific and medical research; nucleic acids, proteins and peptides for laboratory use; diagnostic preparations for clinical or medical laboratory use; diagnostic preparations for scientific or research use other than for medical purposes
Owner
- RinuaGene Biotechnology Co., Ltd., Suzhou, Jiangsu, CN
- RinuaGene Biotechnology Co., Ltd., Suzhou, Jiangsu, CN
Prosecution history
- 14 Oct 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 14 Oct 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 16 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Oct 2024 — SOU EXTENSION 4 GRANTED
- 16 Oct 2024 — SOU EXTENSION 4 FILED
- 16 Oct 2024 — SOU TEAS EXTENSION RECEIVED
- 09 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 May 2024 — CORRECTED NOA E-MAILED
- 08 May 2024 — DIVISIONAL PROCESSING COMPLETE
- 12 Apr 2024 — DIVISIONAL REQUEST RECEIVED
- 08 May 2024 — SOU EXTENSION 3 GRANTED
- 12 Apr 2024 — SOU EXTENSION 3 FILED
- 23 Apr 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 12 Apr 2024 — TEAS REQUEST TO DIVIDE RECEIVED
- 12 Apr 2024 — SOU TEAS EXTENSION RECEIVED